SEC Form 4 · accession 0001209191-17-038423
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
Jun 5, 2017
Accepted (ET)
Jun 7, 2017 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2017 | S | 4,311 | $43.321 | D | 59,559 | D | |
| Common StockF2 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF2 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- F2Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.